Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstructive Sleep Apnea
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Group A: Fentanyl-Based Analgesia, Group B: Opioid-Free Multimodal Analgesia.
- Who it may be relevant to
- Registry conditions: Adenotonsillectomy, Obstructive Sleep Apnea (OSA), Fentanyl, Opioid. Basic parameters: 5 years — 10 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Emphasize that the usage of multimodal analgesia in managing perioperative pain in children with mild to moderate Obstructive Sleep Apnea undergoing adenotonsillectomy may achieve the same efficacy of fentanyl with less respiratory complications and less opioid-related side effects.
Detailed description
Obstructive Sleep Apnea in pediatrics is a sleep disorder characterized by repeated episodes of partial or complete upper airway obstruction during sleep, leading to disrupted breathing, poor sleep quality, and potential developmental and health issues.
Since adeno-tonsillar hypertrophy and enlarged tonsils \& adenoids are the most common causes of pediatric Obstructive Sleep Apnea ,thus adenotonsillectomy is the first-line surgical treatment and is one of the most common pediatric surgeries that has a high success rate in resolving Obstructive Sleep Apnea symptoms with cure rate up to 80%.
Adenotonsillectomy is a common surgical procedure in pediatric patients and perioperative pain management with opioids is common and associated with side effects and risks. Consequently, analgesic strategies to reduce opioid utilization have been developed, because Obstructive Sleep Apnea patients are more sensitive to opioids.
Fentanyl has demonstrated efficacy in pediatrics for acute pain management but still has the risk of opioids induced ventilatory impairment which is very common in children with obstructive sleep apnea due to altered volume of distribution and clearance.
A multimodal analgesia approach, which combines various non-opioid medications (acetaminophen, non-steroidal anti-inflammatory drugs, dexamethasone and ketamine ) can effectively manage perioperative pain in children with mild to moderate Obstructive Sleep Apnea with (apnea hypoxia index \<or= 10) undergoing adenotonsillectomy, while minimizing the risks associated with opioid use.
The purpose of this study is to emphasize that the usage of multimodal analgesia in managing perioperative pain in children with mild to moderate OSA undergoing adenotonsillectomy may achieve the same efficacy of fentanyl with less respiratory complications and less opioid-related side effects.
Interventions
- Drug Group A: Fentanyl-Based Analgesia
Fentanyl-Based Analgesia will receive intraoperative fentanyl (1 μg/kg IV) with standard anesthetic care with postoperative rescue analgesia with acetaminophen (15 mg/kg) as needed - Drug Group B: Opioid-Free Multimodal Analgesia
Opioid-Free Multimodal Analgesia will receive preoperative acetaminophen (15 mg/kg) and ibuprofen (10 mg/kg), intraoperative ketamine (0.5 mg/kg IV) and dexamethasone (0.1 mg/kg IV) with postoperative rescue analgesia with acetaminophen as needed.
Primary outcome measures
- FLACC Scale (face, legs, activity, cry, consolability) [Time frame: at 0 hours, 2hours, and 6 hours postoperatively]
Secondary outcome measures (1)
- Time to oral intake [Time frame: 6 hours postoperatively]
Eligibility criteria
Inclusion criteria
- Children aged 5-10 years.
- Diagnosed with mild to moderate Obstructive Sleep Apnea (apnea-hypoxia index 1-10).
- Scheduled for elective adenotonsillectomy.
- American Society of Anesthesiologists physical status I-II.
Exclusion criteria
- Severe Obstructive Sleep Apnea (apnea-hypoxia index >10).
- Known allergies to study medications.
- Patient with predicted difficult air way (Mallampatti 3\&4).
- History of opioid use or chronic pain syndromes.
- Neurological or metabolic disorders affecting pain perception.
- Parental refusal to consent.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Prevention
Study locations
Egypt · 1 center
- Ain shams university — Cairo
Identifiers
NCT: NCT07435493 · FMASU MD141/2025